20 episodes

Policy development, politics, & government issues are a major part of healthcare. PolitiTalkRx is a podcast all about the politics that shape pharmacy policies within our healthcare system. 

Contact us to participate in this publication part of the leading podcast network dedicated to the "Business of Pharmacy" -- the Pharmacy Podcast Network. 

PolitiTalkR‪x‬ Pharmacy Podcast Network

    • Careers

Policy development, politics, & government issues are a major part of healthcare. PolitiTalkRx is a podcast all about the politics that shape pharmacy policies within our healthcare system. 

Contact us to participate in this publication part of the leading podcast network dedicated to the "Business of Pharmacy" -- the Pharmacy Podcast Network. 

    The Supreme Court Rules in Favor of Pharmacy | Locked On Pharmacy

    The Supreme Court Rules in Favor of Pharmacy | Locked On Pharmacy

    On Dec. 10, 2020, the U.S. Supreme Court ruled 8-0 that an Arkansas law regulating how PBMs and pharmacies interact could be enforced, and was not preempted by federal law.

    With more than three dozen other states debating or passing such legislation, the ruling could have nationwide impact. The CEOs of national pharmacy organization were unanimous in hailing the decision.

    In this episode, three guests discuss the case: Rep. Buddy Carter (R-Georgia); John Vinson, CEO of the Arkansas Pharmacists Association; and Scott Knoer, Executive Vice President and CEO of the American Pharmacists Association.

    See omnystudio.com/listener for privacy information.

    • 24 min
    Georgia State Representative David Knight & GPhA Greg Reybold | PBM Reform Podcast Series

    Georgia State Representative David Knight & GPhA Greg Reybold | PBM Reform Podcast Series

    Georgia Gov. Brian Kemp (R) has signed three innovative PBM reform bills into law. HB 946 and SB 313 require the reporting of drugs paid 10 percent above and 10 percent below National Average Drug Acquisition Cost every four months, prohibit PBMs from tying a pharmacy’s drug reimbursement to a patient’s health outcomes, and require PBMs to offer drug coverage plans that do not include spread pricing and plans that allow plan sponsors to receive 100 percent of rebates negotiated by PBMs. 

    HB 918 strengthens existing anti-steering provisions and the Pharmacy Audit Bill of Rights. Congratulations to the Georgia Pharmacy Association and all pharmacy advocates for these wins which will protect pharmacies, patients, and payers. 

    Guests: Georgia State Representative David Knight

    Greg Reybold Vice President of Public Policy and Association Counsel

    Hosted by Lauren (Colee) Young 

    Sponsored by The Georgia Pharmacy Association & Pharmacists United for Truth and Transparency (PUTT) 

     

    http://www.gpha.org/membership/ 

    See omnystudio.com/listener for privacy information.

    • 49 min
    Insights from the Virginia Pharmacists Association | PUTTcast Episode 05

    Insights from the Virginia Pharmacists Association | PUTTcast Episode 05

    PUTTcast Episode 5 - Chatting with VPhA

    Guests: Christina Barrelle, Executive Director of VPhA, Howard Estes, Attorney & VPhA Lobbyist, Co-Hosts PUTT Executive Director Monique Whitney & PUTT Board President Scott Newman


    PUTT chats with the Virginia Pharmacists Association about building relationships with state legislators, their recent win in PBM reform, and how they managed to catch the PBM lobby off guard to get things done.

    See omnystudio.com/listener for privacy information.

    • 39 min
    Diana Harshbarger for Tennessee | Income Outcomes Show

    Diana Harshbarger for Tennessee | Income Outcomes Show

    As a practicing Pharmacist, Diana Harshbarger could go on for days about the horrible effects Obamacare has had on the healthcare industry, as well as everyday Americans. Health insurance companies and government bureaucrats are out of control. Authority of healthcare choices should be given back to patients and healthcare providers. 

    While there is much work to be done to eliminate the overreaching arm of the federal government when it comes to healthcare, the first steps Diana will take in Congress will be to lower prescription drug prices, increase generic drug pricing transparency as well as increase competition among health insurance plans. These reforms will make it easier for Americans, especially our seniors, to afford their medications.

    This episode is sponsored by the University of California Irvine, UCI, Master of Science in Pharmacology, learn more: https://sites.uci.edu/mspharmacology/ 

    See omnystudio.com/listener for privacy information.

    • 29 min
    Pharmacy Owners Talk Florida Data Impact - PPN Episode 948

    Pharmacy Owners Talk Florida Data Impact - PPN Episode 948

    PUTTCast Host & Executive Director of PUTT - Monique Whitney talks with: 
    Kevin Dwayne - Jacksonville FL w/ Panama Rx 
    Jay Wright - Cocoa FL w/ 5 Points Pharmacy 
    Amy Rodgers - Little Rock AR  w/ City Pharmacy 

    A new Florida study, released last week, found that major health care companies using pharmacy benefit managers (PBM’s) have positioned themselves to pocket millions of dollars from the state’s Medicaid system that were intended to lower costs for millions of low-income Floridians. The study found that despite processing less than half of one percent of all pharmacy claims, specialty pharmacies affiliated with PBM’s managed to collect 28 percent of the available profit margin from dispensing prescription drugs.

    The study was commissioned by the Florida Pharmacy Association and American Pharmacy Cooperative Inc. using data obtained from Florida’s Agency for Health Care Administration (AHCA) by the Small Business Pharmacies Aligned for Reform.  Smaller pharmacy operators say the report proves that larger, vertically integrated companies that use PBM’s are using “predatory” business practices that short-circuit the free market.

    State lawmakers expressed alarm at the news and underscored the need for greater transparency and oversight when it comes to PBMs’ role in Florida, particularly regarding situations where PBM’s and managed care companies own the pharmacies where they direct patients.

    “Markets fail when markets get corrupted and that is what has happened here. When the middleman is allowed to own the end-retailer then the middlemen’s incentive to manage cost appropriately for the benefit of the chain is broken,” said State Representative Randy Fine at a press conference to discuss the study.

    According to the study, vertically integrated health care companies – that is, companies where the health insurance company and PBM also control their own pharmacies – have a significant advantage in prescription drug pricing and reimbursement rates over smaller pharmacy operations that only focus on dispensing prescription drugs. These large and powerful organizations then use their leverage and contracts with the state to squeeze dollars from their competitors by requiring patients to go to pharmacies where they have a financial interest. This process frequently involves rewarding their own pharmacy operations with significantly higher reimbursement rates from Medicaid, according to the study.

    The study provided an example of this situation where Sunshine Health directed 95 percent of all claims for generic cancer drug Gleevac to Acaria, its wholly owned specialty pharmacy. It reimbursed this speciality pharmacy an average of $4,399 above the national average cost for the drug.

    “We have a responsibility to assure that there is no manipulation of prices or anti-competitive practices by PBMs and other entities that result in increased costs to patients and push our local pharmacies out of business,” said State Senator Gayle Harrell.

    Small pharmacy operations describe PBMs as shadowy prescription drug middlemen whose practices are driving neighborhood pharmacies out of business while reducing access to care for many Floridians.

    The State of Florida contracts with PBMs to manage Florida’s Medicaid program in order to negotiate lower drug prices. But the new study concludes that PBMs have actually cost the public millions of dollars by forcing patients to use PBM-affiliated pharmacies and then charging higher prescription costs.

    According to Medicaid data contained in the study, one pharmacy in North Miami was responsible for 25% of all managed care claims in Florida for a particular dermatological cream in 2018, receiving a total profit margin of over $1.8 million.

    The independent study by 3 Axis Advisors reviewed more than 359 million prescription drug claims within Florida

    • 42 min
    Congressional Pharmacy NCPA FLY-IN 2020 - PPN Episode 947

    Congressional Pharmacy NCPA FLY-IN 2020 - PPN Episode 947

    NCPA Team Members Anne CassityVP Government Affairs & Karry La Violette Senior Vice President, Government Affairs & Director of Advocacy Center

    Join us on: 

    Tuesday and Wednesday, April 21/22, 2020 at the Hilton, Old Town Alexandria.  

    FLY In. FLY Out. Easy. 

    That’s NCPA’s 2020 Congressional Pharmacy Fly-In – a small investment of your time that can make a whopping difference in how federal law and policy affect your pharmacy practice.

    https://pharmacyflyin.ncpanet.org/

    See omnystudio.com/listener for privacy information.

    • 16 min

Top Podcasts In Careers

Listeners Also Subscribed To